Channel Therapeutics Corporation’s filing revealed that its Director Malamut Richard acquired Company’s shares for reported $9825.0 on Sep 12 ’24. In the deal valued at $0.94 per share,10,400 shares were bought. As a result of this transaction, Malamut Richard now holds 91,565 shares worth roughly $0.13 million.
Then, Francis Knuettel II bought 3,500 shares, generating $3,395 in total proceeds. Upon buying the shares at $0.97, the CEO, Pres., CFO, Treas & Secty now owns 547,710 shares.
Before that, Francis Knuettel II bought 1,700 shares. Channel Therapeutics Corporation shares valued at $1,649 were divested by the CEO, Pres., CFO, Treas & Secty at a price of $0.97 per share. As a result of the transaction, Francis Knuettel II now holds 544,210 shares, worth roughly $0.78 million.
Price Performance Review of CHRO
On Monday, Channel Therapeutics Corporation [AMEX:CHRO] saw its stock fall -22.28% to $1.43. Over the last five days, the stock has gained 10.00%. Channel Therapeutics Corporation shares have risen nearly 123.09% since the year began. Nevertheless, the stocks have fallen -28.14% over the past one year. While a 52-week high of $3.80 was reached on 01/21/25, a 52-week low of $0.45 was recorded on 01/02/25. SMA at 50 days reached $1.6406, while 200 days put it at $1.1175.
Levels Of Support And Resistance For CHRO Stock
The 24-hour chart illustrates a support level at 1.1801, which if violated will result in even more drops to 0.9301. On the upside, there is a resistance level at 1.7900. A further resistance level may holdings at 2.1499. The Relative Strength Index (RSI) on the 14-day chart is 48.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1225, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.03%. Stochastics %K at 42.53% indicates the stock is a holding.
How much short interest is there in Channel Therapeutics Corporation?
A steep rise in short interest was recorded in Channel Therapeutics Corporation stocks on 2025-03-31, dropping by 15623.0 shares to a total of 11827.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 27450.0 shares. There was a decline of -132.1%, which implies that there is a negative sentiment for the stock.
